Mesothelioma Clinical Trials

Below is a list of current mesothelioma clinical trials. You can find additional trials by searching on mesothelioma at National Cancer Institute’s clinical trials website, which you can access by clicking here: http://www.clinicaltrials.gov/ct/screen/SimpleSearch

Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma
Condition: Malignant Peritoneal Mesothelioma
Interventions: Drug: erlotinib hydrochloride; Other: laboratory biomarker analysis
Sponsors: University of Chicago; University of Chicago; National Cancer Institute NCI
Not yet recruiting - verified May 2012

Ganetespib With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma
Condition: Lung Cancer - Malignant Pleural Mesothelioma
Interventions: Drug: Ganetespib; Drug: Placebo
Sponsors: University College, London; University College, London; Cancer Research UK
Not yet recruiting - verified May 2012

Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
Sponsors: Wake Forest University; Wake Forest University; University of Pennsylvania; Mayo Clinic; New York University School of Medicine; Johns Hopkins University; Mount Sinai School of Medicine; Memorial Sloan-Kettering Cancer Center; Mesothelioma Applied Research Foundation, Inc.
Recruiting - verified May 2012

Treating Cancer With Anti-mesothelin Modified Lymphocytes
Conditions: Metastatic Cancer; Pancreatic Cancer; Mesothelioma
Interventions: Drug: Fludarabine; Drug: Cycolphosphamide; Biological: Aldesleukin
Sponsors: National Institutes of Health Clinical Center CC ; National Cancer Institute NCI
Recruiting - verified March 2012

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: PF-03446962
Sponsors: NCIC Clinical Trials Group; NCIC Clinical Trials Group
Recruiting - verified May 2012

Study of ABT-700 in Subjects With Advanced Solid Tumors
Condition: Subjects With Advanced Solid Tumors Including, But Not Limited to Gastric, Head and Neck, NSCLC, Colon, Mesothelioma and Triple Negative Breast Cancer .
Interventions: Drug: ABT-700; Drug: ABT-700 plus erlotinib; Drug: ABT-700 plus Oxaliplatin and Capecitabine
Sponsors: Abbott; Abbott
Recruiting - verified March 2012

Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal; Mesothelioma; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Amatuximab MORab-009
Sponsors: National Institutes of Health Clinical Center CC ; National Cancer Institute NCI
Recruiting - verified April 2012

Early Palliative Care With Standard Oncology Care Versus Standard Oncology Care Alone in Advanced Lung and Non-colorectal Gastrointestinal Malignancies
Conditions: Non-small Cell Lung Cancer; Small Cell Lung Cancer; Mesothelioma; Esophageal Cancer; Gastric Cancer; Liver Cancer; Biliary Cancer
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital
Recruiting - verified April 2012

A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma
Intervention: Drug: ADI-PEG 20
Sponsors: Barts The London NHS Trust; Barts The London NHS Trust; Cancer Research UK; UK: Barts Center for Experimental Cancer Medicine CECM for Trial Coordination
Recruiting - verified May 2012

Tumor Cell Vaccines With ISCOMATRIX Trademark Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural Mesotheliomas
Conditions: Mesolthelioma; Esophageal Cancer; Lung Cancer
Interventions: Drug: Celecoxib; Drug: ISCOMATRIX TM Adjuvant; Biological: Autologous Tumor Cell Vaccine
Sponsors: National Institutes of Health Clinical Center CC ; National Cancer Institute NCI
Recruiting - verified January 2012

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Condition: Life Threatening Diseases
Intervention: Drug: Imatinib mesylate
Sponsors: Novartis; Novartis Pharmaceuticals
Completed - verified April 2012

Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung
Condition: Malignant Mesothelioma
Interventions: Drug: cisplatin; Drug: gemcitabine hydrochloride; Procedure: conventional surgery
Sponsors: Swiss Group for Clinical Cancer Research; Swiss Group for Clinical Cancer Research
Completed - verified May 2012